• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《中国药理学通报》 >氢溴酸樟柳碱对抗大鼠急性脑缺血/再灌注损伤的作用机制研究

氢溴酸樟柳碱对抗大鼠急性脑缺血/再灌注损伤的作用机制研究

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aim To investigate the protective mechanism of anisodine hydrobromide against cerebral ischemia-reperfusion injury in rats.Methods In vivo: the cerebral ischemia-reperfusion injury model was established by middle cerebral artery occlusion(MCAO)via suture method in rats;the rats were injected anisodine hydrobromide(1.2,0.6,0.3,0.15 mg·kg-1);the morphological changes were detected by HE staining;the Nissl staining was used to count the number of surviving neurons;the activity of CAT and LDH,the LPO contents in the brain tissue were measured;the expressions of Bax,Bcl-2,caspase-3 and p-Akt in brain tissue were detected by Western blot.In vitro: Western blot assay was used to determine the expression of Bax,Bcl-2,caspase-3 and p-Akt protein expression in the OGD-R model of PC12 cells.The signal pathway of anisodine hydrobromide was identified.Results Anisodine hydrobromide with the dose of 0.15 mg·kg-1 could significantly lessen the morphological changes,and improve the number of surviving neurons;the dose of 0.3 and 0.15 mg·kg-1 could significantly improve the activity of CAT;the dose of 0.3 mg·kg-1 could significantly reduce the contents of LPO in the rat brain tissue;the dose of 1.2 mg·kg-1 could significantly decrease the activity of LDH;the dose of 0.15～1.2 mg·kg-1 could inhibit the expression of Bax,promote the expression of p-Akt in rat brain tissue.All the doses except 0.15 mg·kg-1 could promote the expression of Bcl-2 in rat brain tissue.In vitro,the results showed that anisodine hydrobromide in 25～100 μmol·L-1 could significantly improve the expression of Bcl-2 and the ratio of Bcl-2/Bax,and the dose of 50 μmol·L-1 could significantly improve the ratio of p-Akt/Akt.Conclusion The mechanism of anisodine hydrobromide against cerebral ischemia-reperfusion injury model rats might be related to its anti-oxidative activity and the activation of Akt.%目的 探讨氢溴酸樟柳碱对抗大鼠急性脑缺血/再灌注损伤的作用机制.方法 体内实验采用线栓法制备大鼠大脑中动脉阻塞(MCAO)致脑缺血/再灌注损伤模型,氢溴酸樟柳碱尾静脉注射进行干预.HE染色评价脑组织一般病理学情况;尼氏染色评价脑组织健存神经元情况;检测脑组织匀浆过氧化氢酶(CAT)活性、脂质过氧化物(LPO)含量、乳酸脱氢酶(LDH)活性;采用Western blot技术检测脑组织Bax、Bcl-2、caspase-3、p-Akt等蛋白的表达.体外实验采用PC12细胞氧糖剥夺再灌注损伤模型(OGD-R),采用Western blot技术检测细胞内Bax、Bcl-2、caspase-3、p-Akt等蛋白的表达情况,对氢溴酸樟柳碱作用的信号通路进行确认.结果 氢溴酸樟柳碱0.15 mg·kg-1能明显降低MCAO模型大鼠一般病理学评分,提高存活神经元数目;氢溴酸樟柳碱0.3、0.15 mg·kg-1能明显提高脑组织CAT活性,氢溴酸樟柳碱0.3 mg·kg-1 能明显降低LPO含量;氢溴酸樟柳碱1.2 mg·kg-1明显降低LDH活性;各剂量组均能明显降低促凋亡蛋白Bax的表达,提高Bcl-2/Bax比值,促进p-Akt表达,明显提高p-Akt/Akt比值,除氢溴酸樟柳碱0.15 mg·kg-1剂量外,其余剂量均能明显提高抗凋亡蛋白Bcl-2的表达.体外实验结果显示,氢溴酸樟柳碱在25～100 μmol·L-1时能明显提高Bcl-2蛋白的表达,提高Bcl-2/Bax比值,在50 μmol·L-1剂量下能明显提高p-Akt/Akt的比值.结论 氢溴酸樟柳碱对抗急性脑缺血/再灌注损伤大鼠的作用机制与抗氧化损伤及提高p-Akt的表达有关.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号